Molecular Diagnostics Systems Market
Molecular Diagnostics Systems Market Size and Growth
The Molecular Diagnostics Systems market is experiencing substantial growth, driven by advancements in technology and increasing demand for rapid disease diagnosis. The market size was valued at approximately $9 billion in 2022 and is projected to reach over $20 billion by 2030, reflecting a robust compound annual growth rate (CAGR). Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Abbott Laboratories
◍ Qiagen N.V.
◍ Roche Diagnostics
◍ Hologic, Inc.
◍ Grifols
◍ Siemens Healthcare
◍ Becton, Dickinson and Company
The molecular diagnostics systems market features major players like Abbott Laboratories, Qiagen N.V., Roche Diagnostics, and others, providing innovative solutions for disease detection. These companies enhance market growth through advanced technologies, strategic partnerships, and expanding test offerings.
Selected revenue figures include:
- Abbott Laboratories: $43 billion
- Roche Diagnostics: $16.2 billion
- Qiagen N.V.: $2.0 billion
◍ Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
◍ Biomérieux Sa
◍ Cepheid Inc
Request Sample Report
Market Segmentation
By Application
Hospitals
Laboratories
Request Sample Report
By Product
PCR
Hybridization
DNA Sequencing
Market Growth
Request Sample Report
$ X Billion USD
